Templeton Growth Adv TGADX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 28.36  /  +1.29 %
  • Total Assets 8.7 Bil
  • Adj. Expense Ratio
    0.790%
  • Expense Ratio 0.790%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Global Large-Stock Blend
  • Investment Style Large Blend
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield 1.09%
  • Turnover 33%

USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis TGADX

Will TGADX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Low Process Pillar rating limit Templeton Growth Adv to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TGADX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 30.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AstraZeneca PLC

4.04 358.2 Mil
Healthcare

UnitedHealth Group Inc

3.25 288.1 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd ADR

3.04 270.1 Mil
Technology

PNC Financial Services Group Inc

2.96 262.4 Mil
Financial Services

Rolls-Royce Holdings PLC

2.93 259.9 Mil
Industrials

Microsoft Corp

2.89 256.0 Mil
Technology

TJX Companies Inc

2.85 252.5 Mil
Consumer Cyclical

Alphabet Inc Class A

2.82 250.4 Mil
Communication Services

Unilever PLC

2.82 249.8 Mil
Consumer Defensive

Bank of America Corp

2.78 246.6 Mil
Financial Services

Sponsor Center